Xcout Intel
RAPT Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to RAPT Therapeutics, Inc. among biotechnology companies — ranked by similarity to what RAPT Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see RAPT Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About RAPT Therapeutics, Inc.
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The firm is driven by its mission to develop oral small molecule therapies to treat inflammatory and immunologic diseases.
RAPT Therapeutics, Inc. at a glance
RAPT Therapeutics, Inc. is a biotechnology company headquartered in United States, founded in 2015. Its most recent funding round raised $150M in December 2024. Xcout tracks 17 named people at RAPT Therapeutics, Inc., including Rodney Young (CFO).
RAPT Therapeutics, Inc. leadership
- Rodney YoungCFO
- Brian WongExecutive Officer
- Dirk BrockstedtExecutive Officer
- Dirk J. BrockstedtExecutive Officer
- Rodney J. YoungExecutive Officer
- Rodney YoungExecutive Officer
11 more named people on record for RAPT Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
RAPT Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $150M | — | |
| SEC Form D filing | $50M | — | |
| Series B | $125M | — | |
| Series B | $50M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent RAPT Therapeutics, Inc. news
Top 12 RAPT Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to RAPT Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ouro Medicines is a biotechnology company headquartered in South San Francisco, California, developing immune reset therapeutics for chronic immune-mediated diseases.
Similar biotechnology company
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Similar biotechnology company
Khartis Therapeutics is a biotechnology company headquartered in San Diego, California, developing oral small molecule medicines for immunological and related treatments.
Similar biotechnology company
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Similar biotechnology company
Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Similar biotechnology company
Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
Similar biotechnology company
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Biotech
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Biotech
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Similar biotechnology company
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Similar biotechnology company
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Similar biotechnology company
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of RAPT Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for RAPT Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →